Literature DB >> 16984869

Emerging fungi.

Marcio Nucci1, Elias Anaissie.   

Abstract

The hyalohyphomycetes (especially Fusarium spp) have emerged as significant pathogens in severely immunocompromised patients. Human infections by Fusarium spp can be superficial or limited to single organs in otherwise healthy patients. Such infections are rare and tend to respond well to therapy. By contrast, disseminated fusarial hyalohyphomycosis affects the immunocompromised host and frequently is fatal. Successful outcome is determined by the degree of immunosuppression and the extent of the infection. These infections may be suspected clinically on the basis of a constellation of clinical and laboratory findings, which should lead to prompt therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16984869     DOI: 10.1016/j.idc.2006.06.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  19 in total

1.  Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Authors:  Maged Muhammed; Marta Feldmesser; Lisa F Shubitz; Michail S Lionakis; Anita Sil; Yan Wang; Justin Glavis-Bloom; Russell E Lewis; John N Galgiani; Arturo Casadevall; Dimitrios P Kontoyiannis; Eleftherios Mylonakis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

2.  Acremonium strictum: Report of a Rare Emerging Agent of Cutaneous Hyalohyphomycosis with Review of Literatures.

Authors:  Ajanta Sharma; N K Hazarika; Purnima Barua; M R Shivaprakash; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2013-10-12       Impact factor: 2.574

Review 3.  Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature.

Authors:  Greg P Bourgeois; Jennifer A Cafardi; Klaus Sellheyer; Aleodor A Andea
Journal:  Cutis       Date:  2010-04

Review 4.  Invasive fungal infections in transplant recipients.

Authors:  Jose A Vazquez; Marisa H Miceli; George Alangaden
Journal:  Ther Adv Infect Dis       Date:  2013-06

Review 5.  Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.

Authors:  Shukla Das; Rumpa Saha; Sajad Ahmad Dar; V G Ramachandran
Journal:  Mycopathologia       Date:  2010-06-25       Impact factor: 2.574

6.  Acremonium kiliense: reappraisal of its clinical significance.

Authors:  Ziauddin Khan; Khaled Al-Obaid; Suhail Ahmad; Amal Abdel Ghani; Leena Joseph; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

7.  The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system.

Authors:  Maged Muhammed; Beth Burgwyn Fuchs; Michael P Wu; Julia Breger; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  Med Mycol       Date:  2012-01-09       Impact factor: 4.076

8.  A Clonal Lineage of Fusarium oxysporum Circulates in the Tap Water of Different French Hospitals.

Authors:  Véronique Edel-Hermann; Marc Sautour; Nadine Gautheron; Julie Laurent; Serge Aho; Alain Bonnin; Nathalie Sixt; Philippe Hartemann; Frédéric Dalle; Christian Steinberg
Journal:  Appl Environ Microbiol       Date:  2016-10-14       Impact factor: 4.792

9.  Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.

Authors:  Jorge Meneses Nunes; Fernando César Bizerra; Renata Carmona E Ferreira; Arnaldo Lopes Colombo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 10.  Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.

Authors:  Mario Delia; Rosa Monno; Giorgia Giannelli; Amato Antonio Stabile Ianora; Lidia Dalfino; Domenico Pastore; Carmen Capolongo; Carla Calia; Annamaria Tortorano; Giorgina Specchia
Journal:  Mycopathologia       Date:  2016-03-23       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.